Research Article

Seroprevalence against Rickettsia and Borrelia Species in Patients with Uveitis: A Prospective Survey

Table 1

Results of serology for the Rickettsia spp. in serum S1–S5 and Borrelia spp. in S2 for all patients diagnosed with uveitis.

GroupPat. numberGender/ageS1WeeksS2WeeksS3WeeksS4WeeksS5Borrelia/s (S2) IgG/IgM
IgGIgMS1–S2IgGIgMS1-S3IgGIgMS1-S4IgGIgMS1-S5IgGIgM

11M/6464<6455126417256<64Pos/border
2M/41<6464141282564564128Neg/neg
3F/13<641285<645121025651226512102451128256Neg/neg
4F/51<64512412812817128<64Neg/neg
5F/726464425612820128<64Neg/neg
6M/69<64<648256<6420256<6432128<64Neg/neg
7F/43645126256102422256256Neg/neg

28F/6951251255125122012864Neg/neg
9M/655125125512512191024204834256256Neg/neg
10M/3912864964<64162565123364128Neg/neg
11F/66102410245102420481951251233256256Neg/neg
12M/665122564102412824256256Neg/neg
13M/52128256122565122712851248128128Border/neg
14F/6025651252561282225612832256128Neg/neg
15M/58128<645256<6421<64<64Neg/neg
16M/50256<641164<64Neg/pos
17M/37256256612812818128128Neg/neg
18F/59128<647256<6425128<64Pos/neg
19F/3825625611512256Neg/neg

320F/7764<64564<64Neg/pos
21M/5564<64664<64Neg/neg
22M/4864<646128<641964<64Neg/neg
23F/68<641285<64<64Neg/neg
24M/711281284128642364<64Neg/neg
25M/2664<641264<64Neg/neg
26F/5212851212128643464<64Neg/neg
27M/3864<6451286421<64<64Neg/neg
28F/6364<64664<64Neg/pos
29F/4464645<6464Border/neg
30M/67128<64464<64Pos/neg
31F/2564<64764<64Neg/neg
32M/4264<64764<64Neg/neg
33M/62128641764<64Neg/neg
34F/18<64<6456464Neg/neg
35F/5412812896412814128128Neg/neg

436M/72<64<649<64<64Neg/neg
37F/65<64<6410<64<64Neg/neg
38M/27<64<645<64<64Neg/neg
39M/47<64<645<64<64Neg/neg
40M/70<64<644<64<64Neg/neg
41F/58<64<646<64<64Neg/neg
42F/53<64<646<64<64Neg/neg
43M/64<64<6410<64<64Neg/neg
44M/53<64<6427<64<64Neg/neg
45M/60<64<644<64<64Neg/neg
46M/53<64<645<64<64Neg/neg
47M/33<64<646<64<64Neg/neg
48M/47<64<646<64<64Neg/neg

Pat. number: patient number; M: male; F: female; S1–S5: serum samples 1–5.